Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase Specificity
Biochemical Medicine and Metabolic Biology · 1993
DOI: 10.1006/bmmb.1993.1022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Medicine and Metabolic Biology, 1993. Verfasst von W C Spence und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics, Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201-0509. Hauptthemen laut MEDLINE: Neonatal Screening. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PHS HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Genetics, Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201-0509.
Förderung
- PHS HHS
Zitieren
APA
Spence, W. C., Paulus-Thomas, J., Orenstein, D. M., & Naylor, E. W. (1993). Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase Specificity. Biochemical Medicine and Metabolic Biology. https://doi.org/10.1006/bmmb.1993.1022
Vancouver
Spence WC, Paulus-Thomas J, Orenstein DM, Naylor EW. Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase Specificity. Biochemical Medicine and Metabolic Biology. 1993. doi:10.1006/bmmb.1993.1022
BibTeX
@article{Spence1993,
author = {Spence, W C and Paulus-Thomas, J and Orenstein, D M and Naylor, E W},
title = {Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase Specificity},
journal = {Biochemical Medicine and Metabolic Biology},
year = {1993},
doi = {10.1006/bmmb.1993.1022}
}
EUVIMED